AERI
Aerie Pharmaceuticals
AERI
AERI
Delisted
AERI was delisted on the 18th of November, 2022.
98 hedge funds and large institutions have $641M invested in Aerie Pharmaceuticals in 2014 Q4 according to their latest regulatory filings, with 34 funds opening new positions, 28 increasing their positions, 25 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
12% more repeat investments, than reductions
Existing positions increased: 28 | Existing positions reduced: 25
Holders
98
Holding in Top 10
3
Calls
–
Puts
–
Top Buyers
1 | +$62.4M | |
2 | +$19.6M | |
3 | +$12.6M | |
4 |
NHAS
Novo Holdings A/S
Hellerup,
Denmark
|
+$12.3M |
5 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$9.47M |
Top Sellers
1 | -$37.9M | |
2 | -$13.6M | |
3 | -$10.4M | |
4 |
Goldman Sachs
New York
|
-$6.48M |
5 |
PA
Perceptive Advisors
New York
|
-$5.44M |